DISCLAIMER:

We are not responsible for the actions, projects, token distrubition, or infromation of third parties - companies running their own projects. Please note that we act solely as a platform in an intermediary role. We do not in any way influence or relate to third parties token sale.

Curaizon

Improving Healthcare, Reducing Costs, Saving Lives We’re revolutionizing healthcare and improving drug-adherence through big data analytics delivered via the blockchain

PROJECT DETAILS

31 Aug 2018
31 Dec 2018
CURA

About the project

CuraServeTM is a complete healthcare ecosystem that improves drug adherence and brings game‐changing benefits to patients and healthcare providers. We use a series of outreach tools and messages, supported by predictive modeling and behavioral analytics, to increase the rate of drug adherence. As our CuraServeTM solution helps patients, it’s also generating a vast amount of patient data. That data is then anonymized and made available through CuraDataTM. The only way that pharmaceutical companies, academics and researchers can access this data by purchasing CuraTokensTM. Our data is the first‐of‐its‐kind insight into real‐time patient behavior and adherence. CuraDataTM will finally give the health and pharmaceutical industries the tools they have been looking for to bring about the change patients need. Our value‐based approach to a simple, accessible, yet valuable exchange of data and analysis will revolutionize healthcare. Healthcare is changing forever and CuraServeTM stands at the cutting edge of this transformation. CuraizonTM is the UK‐based company that has developed CuraServeTM.

Team

Nicholas James Rumble
Chief Executive Officer (CEO)
Chris Matey
Chief Operations Officer (COO)
Mark Nathan
Chief Financial Officer (CFO)
Darran Trute
Chief Technology Officer (CTO)